Latest stories on TXMD
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains
MarketWatch42 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors
MarketWatch38 · neutralgeneral
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors
MarketWatch42 · neutralgeneral
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors
MarketWatch42 · neutralgeneral
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
TherapeuticsMD Q2 Results and Strategic Alternatives Review
TipRanks50 · neutralearnings
TherapeuticsMD, Inc. (TXMD) files 8-K
SEC 8-K50 · neutralgeneral
TherapeuticsMD Announces Second Quarter 2026 Financial Results
StockTitan50 · neutralgeneral